A bioequivalence study proves that the generic drug gets into a patient's bloodstream in the same amount and at the same rate as the original brand, which is the key to its therapeutic effect. Some copies, like certain simple topical creams, are approved through alternative scientific assessments because their action is local, not systemic. From my desk at CDSCO, I see this as a careful balance between rigorous science and practical access—ensuring every "janata" gets affordable medicine without compromising an ounce of safety. It reminds me of my father’s stitching: the final garment from two tailors may look identical, but what truly matters is the strength and integrity of every hidden seam.
#exams#study
Jump in to reply — no account needed.